Kuria Therapeutics

Kuria Therapeutics is a biotechnology company focused on powering sight through the development of a novel platform of Nrf2 activators designed to treat blinding diseases. Located in Research Triangle Park, North Carolina, Kuria Therapeutics is dedicated to advancing innovative therapies to address significant unmet needs in ophthalmology.

Kuria Therapeutics is committed to scientific excellence and the development of groundbreaking treatments. The company's primary address is in Research Triangle Park, North Carolina, where its team is diligently working to translate cutting-edge research into effective solutions for patients suffering from vision loss. Kuria Therapeutics aims to improve the quality of life for individuals worldwide by preserving and restoring eyesight.

Kuria Therapeutics is poised for continued growth and impact in the biotechnology sector. The company is actively involved in research and development, striving to bring new hope to those affected by blinding conditions. We invite the management team at Kuria Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further enhance your visibility and commercial development.